Betulin binds to melanocortin receptors and antagonizes alpha-melanocyte stimulating hormone induced cAMP generation in mouse melanoma cells.
Muceniece. Ruta R; Saleniece. Kristine K; Riekstina. Una U; Krigere. Liga L; Tirzitis. Gunars G; Ancans. Janis J
Key Findings
- Betulin binds human MC1R with ~1 µM affinity and also binds MC3, MC4, MC5 with lower affinity
- Betulin does not stimulate cAMP production but slightly antagonizes alpha‑MSH‑induced cAMP in melanoma cells
- High concentrations of DMSO (≥20%) also compete for MC receptor binding, showing solvent effects
Practical Outcomes
- For biohackers, betulin isn’t a direct substitute or enhancer for melanotan‑I and offers no clear dosing guidance. It may be of interest for those exploring natural compounds that modulate skin‑pigment or anti‑cancer pathways, but more research is needed before any real‑world protocol can be recommended.
Summary
Betulin, a compound from birch bark, can stick to several melanocortin receptors (especially MC1R) but doesn’t trigger the usual signaling; instead it mildly blocks the natural hormone alpha‑MSH from raising cAMP levels in mouse melanoma cells. This makes betulin a rare non‑peptide molecule that interacts with these receptors, though it’s not a strong activator.
Abstract
Betulin is a principal component of birch bark and is known to possess a broad range of biological activities, including antiinflammatory, antiviral and anticancer actions. The present study was carried out in vitro to clarify the influence of betulin on melanocortin (MC) receptor-ergic signalling by using COS-7 cells transfected with corresponding human MC receptor DNA. The results showed that betulin binds to the human melanocortin MC1, three to five receptors with selectivity to the MC1 subtype (K(i) value 1.022 +/- 0.115 microM). Betulin binds to the MC receptors with the following potency order-MC > MC3 > MC5 > MC4. Betulin itself does not stimulate cAMP generation, however, it slightly antagonizes alpha-melanocyte-stimulating hormone (alpha-MSH)-induced cAMP accumulation in the mouse melanoma cell line B16-F1. As a water-insoluble substance, betulin was dissolved in DMSO therefore DMSO competition with the labelled ligand NDP-MSH for the binding to the MC receptors was tested in the identical experimental set-up. We found that DMSO competes for binding to all the MC receptor subtypes, at 20% concentration and above. Selectivity for one or another receptor subtype was not observed. We have demonstrated for the first time, the ability of the plant compound betulin to bind to the MC receptors. One may suggest MC receptor MC1 subtype as the essential target for the antimelanoma action of betulin and its structurally close molecules such as betulinic acid. Moreover, we have found a new non-peptide small molecule MC mimetic, that is betulin. Thus, we report a new chemical motif for the binding to the MC receptors that could be used as a template for the search of more selective MC mimetics.
Study Information
pubmed
2007
2007-09-01T00:00:00.000Z
10.1002/cbf.1427
20
32